Journal of Translational Medicine

Table 3 Number of probe sets that significantly differed in expression (p ≤ 0.001).

From: Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment

Fold Change	Expected*	Day 3	Day 6	Day 10	Day 13	Day 27	Day 42	Day 70
NA**	11	973	478	725	471	716	452	920
≥ 1.5	-†	290	165	255	142	194	157	289
%≥ 1.5		30%	35%	35%	30%	27%	35%	31%
Up regulated
Fold Change	Expected*	Day 3	Day 6	Day 10	Day 13	Day 27	Day 42	Day 70
NA**	-†	472	237	344	229	340	234	406
≥ 1.5	-†	235	96	294	102	129	103	206
%≥ 1.5		50%	41%	85%	45%	38%	44%	51%
Down regulated
Fold Change	Expected*	Day 3	Day 6	Day 10	Day 13	Day 27	Day 42	Day 70
NA**	-†	501	241	381	242	376	218	514
≤ -1.5	-†	55	32	61	40	65	54	83
%≥ 1.5		11%	13%	16%	17%	17%	25%	16%

* Expected for normal distribution
** Not applicable; No fold change cutoff applied
† Not applicable

Back to article page

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com